SAN DIEGO—For treatment of T1b esophageal cancer, endoscopic resection and surgical resection are associated with similar rates of recurrence and five-year overall survival, according to a meta-analysis presented at the 2022 Digestive Disease Week.
“Based on the pooled data, esophageal resection appears to be an attractive alternative to surgical resection, specifically in patients with esophageal cancer limited to the superficial submucosa,” said Anand Kumar, MD, a